These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 20507579)

  • 1. Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population.
    Liu CS; Hsu HS; Li CI; Jan CI; Li TC; Lin WY; Lin T; Chen YC; Lee CC; Lin CC
    BMC Gastroenterol; 2010 May; 10():51. PubMed ID: 20507579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abdominal obesity, glucose intolerance and decreased high-density lipoprotein cholesterol as components of the metabolic syndrome are associated with the development of colorectal cancer.
    Choi YJ; Lee DH; Han KD; Shin CM; Kim N
    Eur J Epidemiol; 2018 Nov; 33(11):1077-1085. PubMed ID: 30196334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated Neutrophil-to-Lymphocyte Ratio in Metabolic Syndrome Is Associated with Increased Risk of Colorectal Adenoma.
    Kim JH; Cho KI; Kim YA; Park SJ
    Metab Syndr Relat Disord; 2017 Oct; 15(8):393-399. PubMed ID: 28910195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Metabolic Profiles are Associated with Colorectal Adenomas and Serrated Polyps.
    Fliss-Isakov N; Zelber-Sagi S; Webb M; Halpern Z; Shibolet O; Kariv R
    Obesity (Silver Spring); 2017 Nov; 25 Suppl 2():S72-S80. PubMed ID: 29086511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stepwise relationship between components of metabolic syndrome and risk of colorectal adenoma in a Taiwanese population receiving screening colonoscopy.
    Hu NC; Chen JD; Lin YM; Chang JY; Chen YH
    J Formos Med Assoc; 2011 Feb; 110(2):100-8. PubMed ID: 21377064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender difference in metabolic syndrome and incident colorectal adenoma: A prospective observational study (KCIS No.42).
    Ku MS; Chiu SY; Chien KL; Lee YC; Chen SL; Chen CD
    Medicine (Baltimore); 2021 Jun; 100(22):e26121. PubMed ID: 34087861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of colorectal adenoma with components of metabolic syndrome.
    Kim BC; Shin A; Hong CW; Sohn DK; Han KS; Ryu KH; Park BJ; Nam JH; Park JW; Chang HJ; Choi HS; Kim J; Oh JH
    Cancer Causes Control; 2012 May; 23(5):727-35. PubMed ID: 22450737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome and colorectal adenoma risk: A systematic review and meta‑analysis.
    Wu H; Zhang J; Zhou B
    Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101749. PubMed ID: 34214702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity-related parameters and colorectal adenoma development.
    Kim TJ; Kim JE; Choi YH; Hong SN; Kim YH; Chang DK; Rhee PL; Kim MJ; Jung SH; Son HJ
    J Gastroenterol; 2017 Dec; 52(12):1221-1229. PubMed ID: 28197803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Distribution characteristics and risk factors of colorectal adenomas].
    Zhou H; Shen Z; Zhao J; Zhou Z; Xu Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jun; 21(6):678-684. PubMed ID: 29968244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low urine pH affects the development of metabolic syndrome, associative with the increase of dyslipidemia and dysglycemia: Nationwide cross-sectional study (KNHANES 2013-2015) and a single-center retrospective cohort study.
    Chung SM; Moon JS; Yoon JS; Won KC; Lee HW
    PLoS One; 2018; 13(8):e0202757. PubMed ID: 30142166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visceral obesity and insulin resistance as risk factors for colorectal adenoma: a cross-sectional, case-control study.
    Kang HW; Kim D; Kim HJ; Kim CH; Kim YS; Park MJ; Kim JS; Cho SH; Sung MW; Jung HC; Lee HS; Song IS
    Am J Gastroenterol; 2010 Jan; 105(1):178-87. PubMed ID: 19755965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome and risks of colon and rectal cancer: the European prospective investigation into cancer and nutrition study.
    Aleksandrova K; Boeing H; Jenab M; Bas Bueno-de-Mesquita H; Jansen E; van Duijnhoven FJ; Fedirko V; Rinaldi S; Romieu I; Riboli E; Romaguera D; Overvad K; Østergaard JN; Olsen A; Tjønneland A; Boutron-Ruault MC; Clavel-Chapelon F; Morois S; Masala G; Agnoli C; Panico S; Tumino R; Vineis P; Kaaks R; Lukanova A; Trichopoulou A; Naska A; Bamia C; Peeters PH; Rodríguez L; Buckland G; Sánchez MJ; Dorronsoro M; Huerta JM; Barricarte A; Hallmans G; Palmqvist R; Khaw KT; Wareham N; Allen NE; Tsilidis KK; Pischon T
    Cancer Prev Res (Phila); 2011 Nov; 4(11):1873-83. PubMed ID: 21697276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Incidence of metabolic syndrome and associated lifestyle factors in a worksite male population].
    Otsuka T; Kawada T; Yanai M; Kitagawa Y; Kan H
    Sangyo Eiseigaku Zasshi; 2011; 53(3):78-86. PubMed ID: 21372516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between metabolic syndrome and kidney cancer risk: a prospective cohort study.
    Wang L; Du H; Sheng C; Dai H; Chen K
    Lipids Health Dis; 2024 May; 23(1):142. PubMed ID: 38760801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the impact of metabolic syndrome and its components on reflux esophagitis? A cross-sectional study.
    Hsieh YH; Wu MF; Yang PY; Liao WC; Hsieh YH; Chang YJ; Lin IC
    BMC Gastroenterol; 2019 Feb; 19(1):33. PubMed ID: 30782138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of body fat distribution and metabolic syndrome with the occurrence of colorectal adenoma: A case-control study.
    Liu ZH; Zhang GX; Zhang H; Jiang L; Deng Y; Chan FSY; Fan JKM
    J Dig Dis; 2021 Apr; 22(4):222-229. PubMed ID: 33656773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association of colorectal adenoma and metabolic syndrome and relevant parameters].
    Liu Z; Hu X; Cui S; Gu J; Joe King Man F; Fion Siu Yin C; Peng J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jun; 19(6):675-9. PubMed ID: 27353103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of adenomas and hyperplastic polyps in mismatch repair mutation carriers among CAPP2 participants: report by the colorectal adenoma/carcinoma prevention programme 2.
    Liljegren A; Barker G; Elliott F; Bertario L; Bisgaard ML; Eccles D; Evans G; Macrae F; Maher E; Lindblom A; Rotstein S; Nilsson B; Mecklin JP; Möslein G; Jass J; Fodde R; Mathers J; Burn J; Bishop DT
    J Clin Oncol; 2008 Jul; 26(20):3434-9. PubMed ID: 18612159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between metabolic syndrome and early-stage colorectal cancer.
    Zhang C; Zhang L; Tian Y; Guan B; Li S
    BMC Cancer; 2023 Oct; 23(1):1020. PubMed ID: 37872512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.